| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910456613603321 |
|
|
Autore |
Meesters Janine <1981-> |
|
|
Titolo |
The meaning of activities in the dwelling and residential environment [[electronic resource] ] : a structural approach in people-environment relations / / door Janine Meesters |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Amsterdam, : IOS Press |
|
Delft, : Delft University Press, c2009 |
|
|
|
|
|
|
|
|
|
ISBN |
|
6612454539 |
1-282-45453-6 |
9786612454530 |
1-60750-433-2 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (286 p.) |
|
|
|
|
|
|
Collana |
|
Sustainable urban areas, , 1574-6410 ; ; 27 |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Housing |
Housing - Resident satisfaction |
Housing - Psychological aspects |
Human beings - Effect of environment on |
Urban ecology (Sociology) |
City and town life |
Lifestyles |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Originally presented as the author's thesis (doctoral)--Delft University of Technology, Delft, 2009. |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references (p. 177-184). |
|
|
|
|
|
|
Nota di contenuto |
|
Title Page; Contents; Preface; Introducing the meaning of dwelling; Conceptualising the meaning of dwelling; Describing the context of dwelling; Analysing activities in the dwelling and the residential environment; The meaning of activities in the dwelling and residential environment; Comparing the meaning of dwelling; Conclusions and discussion; References; Appendix 1 Design and implementation of the questionnaire; Appendix 2 Key features of respondents; Appendix 3 Log linear analysis; Appendix 4 Preferred amenities; Appendix 5 Mentioned activities and the frequencies |
|
|
|
|
|
|
|
|
|
|
|
|
|
Appendix 6 CA of everyday activitiesAppendix 7 Results logistic regression models: activities; Appendix 8 General meanings; Appendix 9 Results logistic regression models: general meanings of activities; Appendix 10 Universal value types; Appendix 11 Use of the dwelling; Appendix 12 Preferred location and main reason for preference; Appendix 13 Activities performed in the living room; Summary; Samenvatting (Dutch summary); Curriculum Vitae; Sustainable Urban Areas |
|
|
|
|
|
|
Sommario/riassunto |
|
The dwelling is a central setting in people's everyday life. People use their dwelling and residential environment for a large variety of activities and purposes. This book relates activities, settings and meanings to improve the insight into people-environment relations which is called a meaning structure approach. |
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910797549503321 |
|
|
Titolo |
Food and drug regulation in an era of globalized markets / / edited by Sam F. Halabi |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, England : , : Academic Press, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (258 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Drugs - Law and legislation |
Pharmacy - Law and legislation |
Food law and legislation |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
Nota di contenuto |
|
Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; |
|
|
|
|
|
|
|
|
|
|
|
Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; Introduction |
Approaches to Reduce Drug Development Costs and Speed Innovation Clinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPs |
FDA Establishment Inspections FDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life Cycle |
Cooperation in Inspections Benefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global Trials |
Deciding Whether to Conduct the Foreign Clinical Trial Under an IND Identifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard Medicines |
Combating Falsified and Substandard Medicines through Regulatory Cooperation |
|
|
|
|
|
|
Sommario/riassunto |
|
Food and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India. From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges. Based on the 2014 O' |
|
|
|
|
|
|
|
| |